Leading the way to the earliest possible diagnosis of Lung Cancer through breath analysis.

Lung Cancer is a leading cause of death.

85% of patients are diagnosed at or after stage Three, where there is very little hope of survival.

Lung cancer: the biggest Killer

160,000

 

Mortalities every year in US / 1.6M Worldwide

 

63 million

At Risk in the US

Sources: American Lung Association and CDC 2011 data

THERE IS NO VIABLE SCREENING TEST

 

AVERAGE COST: $1500

 

Lung Cancer typically has no symptoms until later stages of the disease.

Currently, the only FDA approved diagnosis test is a low dose CT scan.

While a valuable test for visually detecting possible abnormalities, it is prohibitively expensive and can indicate false positives.

There simply is no practical screening test for Lung Cancer - as a result, most early cases are tragically only discovered by accident.

VOC ANALYSIS CAN BE PART OF THE SOLUTION

PART OF EVERY ANNUAL CHECKUP

We have technology that identifies the broadest range of key markers more reliably, rapidly and cost-effectively than any other methodology.

Our vision is to be a viable low-cost part of everyone's annual checkup.

VOC Activator

VOC Concentrator

VOC

Sorter

Data

Analytics

OUR GOAL

Microanalysis of breath using mass spectroscopy began in the 1970s and is now a predictably repeatable and accurate science. However, until now, there have been some challenges:

Expensive: Require high vacuums, radioactive sources and pure gases.

Slow: Results take more than 10 hours.

Not Practical: Lab work requires expensive equipment and protocols.

WHAT CAN BE DONE

With a non-invasive breath test, we are working to catch lung cancer earlier, be more precise with diagnosis and make the cost reasonable enough to soon be a part of regular medical checkups. We can make a huge difference.

© 2016 Elemental Sensor  All Rights Reserved

REFERENCES:

Sources: American Lung Association and CDC 2011 data

Nature (2015), Analytical Chemistry (2014), Cancer Medicine (2013), Cancer Cell (2012), American Chemical Society (2012), Nanomedicine (2012), British Jounal of Medicine (2010), British Journal of Cancer (2010), BioMed Central (2009), Clinica Chimica Acta (2009), American Cancer Society (2007), Journal of Chromatography (2005)

 

LET'S BEGIN A CONVERSATION:

- Press, Journalist, Blogger or Researcher

- Partnerships, Licensing or Development

- Investors or other Interested Parties